Marshall Wace, LLP Oyster Point Pharma, Inc. Transaction History

Marshall Wace, LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 14, 2022	SELL	$10.17 - $18.96 $284,210 - $529,856	-27,946 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$11.67 - $18.07 $326,129 - $504,984	27,946 New	27,946 $331,000
Q4 2020 Feb 16, 2021	SELL	$18.13 - $25.18 $238,899 - $331,796	-13,177 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$17.83 - $29.12 $177,961 - $290,646	-9,981 Reduced 43.1%	13,177 $278,000
Q2 2020 Aug 13, 2020	BUY	$27.86 - $35.93 $645,181 - $832,066	23,158 New	23,158 $669,000

19K

Ticker OYST
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 26,831,500
Description
Oyster Point Pharma, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical therapies to treat ophthalmic diseases in the United States. The company's product candidate is TYRVAYA, a nicotinic acetylcholine receptor agonist for the treatment of signs and symptoms of dry ...

Get notified when there are updates to the investment portfolio of Marshall Wace, LLP, based on Form 13F filings with the SEC.

Stay updated on Marshall Wace, LLP with notifications on news.